Condition
Adenocarcinoma Breast
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
3 treatments under study, led by Ltld
Related Conditions
Often studied with 7 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 1 (1)
Trial Status
Unknown1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Ltld1
- Mrhifu Induced Hyperthermia1
- Cyclophosphamide1
Active Sponsors
- Dutch Cancer Society1
- UMC Utrecht1
- Vrienden UMC Utrecht1
- Center for Translational Molecular Medicine1
Top Investigators
UMC Utrecht
Related Conditions
- Breast Cancer1
- Invasive Ductal Breast Cancer1
- Breast Neoplasms1
- Invasive Ductal Carcinoma Of Female Breast1
- Metastatic Breast Cancer1